Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
Clinical trial NCT03597022 · TERMINATED
Trial details
- NCT number
- NCT03597022
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2019-10-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.